erythropoiesis-stimulating agents
Showing 26 - 50 of 8,067
Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)
Recruiting
- Anemia
- Ferric Derisomaltose Injection
- Darbepoetin Alfa Injection
-
Anyang-si, Korea, Republic ofHallym University Medical Center
Mar 13, 2023
Anemia, Renal Insufficiency, Chronic Trial in Japan (Molidustat (BAY85-3934), Darbepoetin alfa)
Completed
- Anemia
- Renal Insufficiency, Chronic
- Molidustat (BAY85-3934)
- Darbepoetin alfa
-
Yatomi, Aichi, Japan
- +60 more
Jan 28, 2021
Dialysis Trial in Murray (Algorithm model-based Aranesp doses, Standard of care)
Not yet recruiting
- Dialysis
- Algorithm model-based Aranesp doses
- Standard of care
-
Murray, Utah
- +1 more
Jun 27, 2023
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Anemia Associated With Chronic Kidney Disease (CKD) Trial in United States (Vadadustat, Mircera®)
Active, not recruiting
- Anemia Associated With Chronic Kidney Disease (CKD)
-
Huntsville, Alabama
- +57 more
Jan 31, 2022
End Stage Renal Disease, Vascular Access Patency Trial in Charlottesville (ticagrelor, Placebo)
Completed
- End Stage Renal Disease
- Vascular Access Patency
- ticagrelor
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia - Hospital West Kidney Center Dialysis
May 13, 2022
Carnitine Deficiency Due to Hemodialysis Trial in Cairo (L-carnitine, isotonic saline)
Recruiting
- Carnitine Deficiency Due to Hemodialysis
- L-carnitine
- isotonic saline
-
Cairo, EgyptAin Shams university
Jul 13, 2023
MDS Trial in Beijing (Roxadustat, Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 17, 2023
MDS Trial in Worldwide (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Los Alamitos, California
- +53 more
Sep 13, 2023
Erythropoietin-Iron Interaction in Anemia of Renal Disease
Active, not recruiting
- Anemia of End Stage Renal Disease
- Specimen collection
-
Louisville, Kentucky
- +2 more
Jul 1, 2021
End Stage Renal Disease (ESRD) Trial in Poitiers (Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™)
Not yet recruiting
- End Stage Renal Disease (ESRD)
- Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™) dialyzer
-
Poitiers, FranceCHU de Poitiers
Jan 12, 2023
Hyperphosphatemia Trial in Los Angeles (Ferric Citrate)
Completed
- Hyperphosphatemia
- Ferric Citrate
-
Los Angeles, CaliforniaKaiser Permanente Los Angeles Medical Center
Jan 3, 2022
Learn More About Order of Different Treatments and Their Effects
Not yet recruiting
- Metastatic Colorectal Cancer
- Regorafenib (Stivarga, BAY73-4506)
- (no location specified)
Nov 13, 2023
MDS, Anemia Trial in Germany (Luspatercept Injection)
Recruiting
- Myelodysplastic Syndromes
- Anemia
- Luspatercept Injection
-
Berlin, Germany
- +18 more
Jan 25, 2023
End Stage Renal Disease (ESRD) Trial in Poitiers, Saint-Benoît (Hemodialysis sessions)
Not yet recruiting
- End Stage Renal Disease (ESRD)
- Hemodialysis sessions
-
Poitiers, France
- +1 more
May 2, 2022
MDS Trial in France, Germany, United States (Oral rigosertib)
Completed
- Myelodysplastic Syndromes
- Oral rigosertib
-
Stanford, California
- +13 more
Jun 15, 2021
Erythropoietin Adverse Reaction Trial in Roskilde (Acetylsalicylic acid)
Recruiting
- Erythropoietin Adverse Reaction
- Acetylsalicylic acid
-
Roskilde, DenmarkMedicinsk afdeling, SUH Roskilde
Aug 15, 2022
Trauma, Traumatic Injury, Traumatic Brain Injury Trial in Worldwide (Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9%)
Recruiting
- Trauma
- +7 more
- Epoetin Alfa 40000 UNT/ML
- Sodium Chloride 0.9%
-
Camperdown, New South Wales, Australia
- +34 more
Nov 9, 2022
Hemodialysis Complication Trial in Ajaltoun (Hemodialysis)
Recruiting
- Hemodialysis Complication
- Hemodialysis
-
Ajaltoun, Keserwan, LebanonSaint-Georges Hospital
Sep 27, 2021
Neonatal Encephalopathy, Hypoxic-Ischemic Encephalopathy Mild Trial in Salt Lake City (Darbepoetin Alfa, Normal Saline)
Completed
- Neonatal Encephalopathy
- Hypoxic-Ischemic Encephalopathy Mild
- Darbepoetin Alfa
- Normal Saline
-
Salt Lake City, UtahUniversity of Utah
Sep 8, 2022
Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)
Not yet recruiting
- Breast Neoplasms
- Trilaciclib
- +7 more
-
Guangzhou, Gangdong, ChinaSun-yat sen university cancer center
Jul 30, 2023
Natural Blood and Blood Product Toxicity Trial in Dhaka (Erythropoietin alpha)
Completed
- Natural Blood and Blood Product Toxicity
- Erythropoietin alpha
-
Dhaka, Bangladesh
- +1 more
Oct 18, 2022